US Patent RE43833 Thiazolidin-4-one derivatives
Patent RE43833 was granted and assigned to Actelion on November, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Boris Mathys0
Christoph Binkert0
Claus Mueller0
Martin Bolli0
Michael Scherz0
Oliver Nayler0
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent RE043833 Thiazolidin-4-one derivatives US Patent RE43833 Thiazolidin-4-one derivatives
Infobox
Patent Number
RE04383300
Patent Number
RE4383300
Edits on 21 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
RE0438330
Date of Patent
November 27, 2012
0Patent Application Number
132057680
Date Filed
August 9, 2011
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
RE0438330
Date of Patent
November 27, 2012
0Patent Application Number
132057680
Date Filed
August 9, 2011
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent RE043833 Thiazolidin-4-one derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
RE043833
Date of patent
November 27, 2012
Patent application number
13205768
Date Filed
August 9, 2011
Patent primary examiner
Find more entities like US Patent RE43833 Thiazolidin-4-one derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
